Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Aortic Interventions: Features

Endovascular Aneurysm Repair (EVAR): "Keeping the Door Open" for the Next Intervention
Videos
Endovascular Aneurysm Repair (EVAR): "Keeping the Door Open" for the Next Intervention
03/14/2020
Eric Ducasse, MD, PhD
Eric Ducasse, MD, PhD
Eric Ducasse, MD, PhD
03/14/2020
Vascular Disease Management
Interview
Improving Patient Selection for EVAR Versus Open Repair
03/09/2020
VDM spoke with Daniel Clair, MD, to discuss the impact of new technologies for aortic aneurysm therapy on the field and which patients are best suited for open abdominal aortic aneurysm repair.
VDM spoke with Daniel Clair, MD, to discuss the impact of new technologies for aortic aneurysm therapy on the field and which patients are best suited for open abdominal aortic aneurysm repair.
VDM spoke with Daniel Clair, MD,...
03/09/2020
Vascular Disease Management
Original Research
Endovascular Repair of Aorto-Enteric Fistulae as a Definitive Treatment Strategy
03/06/2020
Primary AEF is a communication between the aorta and the GI tract due to one of a long list of diseases, while secondary AEF is created after the erosion of an aortic prosthetic graft into the surrounding GI structures.
Primary AEF is a communication between the aorta and the GI tract due to one of a long list of diseases, while secondary AEF is created after the erosion of an aortic prosthetic graft into the surrounding GI structures.
Primary AEF is a communication...
03/06/2020
Vascular Disease Management
Meeting Update
Choosing Between Fenestrated Endografting and Standard EVAR with Adjuncts
03/04/2020
At an International Symposium on Endovascular Therapy (ISET) talk on choosing between fenestrated endografting (FEVAR) and standard..
At an International Symposium on Endovascular Therapy (ISET) talk on choosing between fenestrated endografting (FEVAR) and standard..
At an International Symposium on...
03/04/2020
Vascular Disease Management
Update of TEVAR for Type A Dissection Trial
Videos
Update of TEVAR for Type A Dissection Trial
03/03/2020
Barry Katzen, MD, interviews Joseph Bavaria, MD, on his pioneering work in patients with acute aortic injuries as part of the ARISE trial.
Barry Katzen, MD, interviews Joseph Bavaria, MD, on his pioneering work in patients with acute aortic injuries as part of the ARISE trial.
Barry Katzen, MD, interviews...
03/03/2020
Vascular Disease Management
Kölbel: Stroke in TEVAR
Videos
Kölbel: Stroke in TEVAR
02/28/2020
Tilo Kölbel, MD
Tilo Kölbel, MD
Tilo Kölbel, MD
02/28/2020
Vascular Disease Management
Slide 1
Developing a Ruptured Aortic Aneurysm Program: What Does It Involve?
02/18/2020
Aortic Occlusive Disease: Why These Patients Need to Avoid Open Surgery
02/14/2020
FEVAR in EVAR: what should we expect?
02/14/2020
The Treated, Expanding Aneurysm Sac: How to Proceed?
02/14/2020

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement